(Q44549999)

4 December 2017

title

Alprazolam (a benzodiazepine activating GABA receptor) reduces the neuroendocrine responses to insulin-induced hypoglycaemia in humans (English)

1 reference

4 December 2017

1 reference

1 reference

1 reference

9

1 reference

4 December 2017

Roberta Giordano

1

1 reference

4 December 2017

Silvia Grottoli

2

1 reference

4 December 2017

PierClaudio Brossa

3

1 reference

4 December 2017

Micaela Pellegrino

4

1 reference

4 December 2017

Silvia Destefanis

5

1 reference

4 December 2017

Fabio Lanfranco

6

1 reference

4 December 2017

Laura Gianotti

7

1 reference

4 December 2017

Ezio Ghigo

8

1 reference

4 December 2017

publication date

1 September 2003

1 reference

4 December 2017

published in

Clinical Endocrinology

1 reference

4 December 2017

volume

59

1 reference

4 December 2017

issue

3

1 reference

4 December 2017

page(s)

314-320

1 reference

Effects of dexamethasone and alprazolam, a benzodiazepine, on the stimulatory effect of hexarelin, a synthetic GHRP, on ACTH, cortisol and GH secretion in humans

4 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01847.X

Benzodiazepines and anterior pituitary function

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01847.X

Effects of alprazolam on pituitary-adrenal and catecholaminergic responses to metabolic stress in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01847.X

Does alprazolam, in contrast to diazepam, activate alpha 2-adrenoceptors involved in the regulation of rat growth hormone secretion?

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01847.X

Endocrine and neurophysiologic responses of the pituitary to insulin-induced hypoglycemia: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01847.X

The stimulatory effect of canrenoate, a mineralocorticoid antagonist, on the activity of the hypothalamus-pituitary-adrenal axis is abolished by alprazolam, a benzodiazepine, in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01847.X

Alprazolam, a benzodiazepine, does not modify the ACTH and cortisol response to hCRH and AVP, but blunts the cortisol response to ACTH in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01847.X

Antidepressants and hypothalamic-pituitary-adrenocortical regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01847.X

Clinical and experimental studies on the role of GABA in the regulation of ACTH secretion: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01847.X

Reduction in urinary free cortisol during benzodiazepine treatment of panic disorder.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01847.X

Comparison of tests of stress-released cortisol secretion in pituitary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01847.X

Effects of alprazolam on increases in hormonal and anxiety levels induced by meta-chlorophenylpiperazine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01847.X

Influence of a benzodiazepine, midazolam, and gamma-aminobutyric acid (GABA) on basal somatostatin secretion from cerebral and diencephalic neurons in dispersed cell culture

21 January 2018

1 reference

https://api.crossref.org/works/10.1046%2FJ.1365-2265.2003.01847.X

10.1046/J.1365-2265.2003.01847.X

21 January 2018

Identifiers

DOI

1 reference

4 December 2017

1 reference